Matches in SemOpenAlex for { <https://semopenalex.org/work/W4223492007> ?p ?o ?g. }
Showing items 1 to 63 of
63
with 100 items per page.
- W4223492007 abstract "Autoimmunity seems to play a great role in the pathogenesis of migraine headache pain. There is far more evidence that interferon can exacerbate migraines. We report a case where remission of severe comorbid migraine attacks happened with the start of interferon β1a (Merck, Netherlands) immunomodulation therapy. Therapy for multiple sclerosis was decided according to the severity of the debilitating comorbid migraine headache pain rather than the evolution of multiple sclerosis the far more serious disease.A 63-years old patient suffered for 30-years from migraine headache of severe disability assessment scale (MIDAS) Grade-IV = 27. He also suffered for 25-years from optic-sensory relapsing remitting multiple sclerosis (RRMS). Subcutaneous interferon β1a 44-µg immunomodulation therapy for 4-years resulted in multiple sclerosis complete remission. The start of interferon β1a therapy for multiple sclerosis seemed to help resolving the comorbid migraine attacks. The visual aura premonitory symptom preceding migraine headache would end up with a feeling of post visual aura clearer field of vision and a feeling of wellbeing. As the patient developed secondary progressive multiple sclerosis (SPMS), oral siponimod 2 mg (Novartis, Ireland), currently the only available therapy for SPMS, replaced his interferon therapy. This was associated with a relapse of migraine severe attacks. Reverting back to interferon therapy was again associated with migraine headache remission.Interferon β1a might be an efficic therapy for autoimmune migraine. With numerous immunomodulators currently available for other systemic autoimmune diseases associated with comorbid migraine; examining the effect of these immunomodulatory therapies on comorbid migraine headache could be beneficial in finding a specific immunomodulator therapy for autoimmune migraine." @default.
- W4223492007 created "2022-04-15" @default.
- W4223492007 creator A5083146951 @default.
- W4223492007 creator A5084523788 @default.
- W4223492007 date "2022-04-05" @default.
- W4223492007 modified "2023-10-10" @default.
- W4223492007 title "Migraine, interferon β1a and siponimod immunomodulator therapies" @default.
- W4223492007 cites W1984102564 @default.
- W4223492007 cites W2139560482 @default.
- W4223492007 cites W2156728464 @default.
- W4223492007 cites W2172206530 @default.
- W4223492007 cites W2174602629 @default.
- W4223492007 cites W2769013445 @default.
- W4223492007 cites W2790816436 @default.
- W4223492007 cites W2893872003 @default.
- W4223492007 cites W2955580540 @default.
- W4223492007 doi "https://doi.org/10.1186/s12871-022-01639-z" @default.
- W4223492007 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35382764" @default.
- W4223492007 hasPublicationYear "2022" @default.
- W4223492007 type Work @default.
- W4223492007 citedByCount "1" @default.
- W4223492007 countsByYear W42234920072022 @default.
- W4223492007 crossrefType "journal-article" @default.
- W4223492007 hasAuthorship W4223492007A5083146951 @default.
- W4223492007 hasAuthorship W4223492007A5084523788 @default.
- W4223492007 hasBestOaLocation W42234920071 @default.
- W4223492007 hasConcept C126322002 @default.
- W4223492007 hasConcept C203014093 @default.
- W4223492007 hasConcept C2776497919 @default.
- W4223492007 hasConcept C2777350023 @default.
- W4223492007 hasConcept C2778541695 @default.
- W4223492007 hasConcept C2778577042 @default.
- W4223492007 hasConcept C2780640218 @default.
- W4223492007 hasConcept C71924100 @default.
- W4223492007 hasConceptScore W4223492007C126322002 @default.
- W4223492007 hasConceptScore W4223492007C203014093 @default.
- W4223492007 hasConceptScore W4223492007C2776497919 @default.
- W4223492007 hasConceptScore W4223492007C2777350023 @default.
- W4223492007 hasConceptScore W4223492007C2778541695 @default.
- W4223492007 hasConceptScore W4223492007C2778577042 @default.
- W4223492007 hasConceptScore W4223492007C2780640218 @default.
- W4223492007 hasConceptScore W4223492007C71924100 @default.
- W4223492007 hasIssue "1" @default.
- W4223492007 hasLocation W42234920071 @default.
- W4223492007 hasLocation W42234920072 @default.
- W4223492007 hasLocation W42234920073 @default.
- W4223492007 hasLocation W42234920074 @default.
- W4223492007 hasOpenAccess W4223492007 @default.
- W4223492007 hasPrimaryLocation W42234920071 @default.
- W4223492007 hasRelatedWork W2068304223 @default.
- W4223492007 hasRelatedWork W2078953783 @default.
- W4223492007 hasRelatedWork W2089758442 @default.
- W4223492007 hasRelatedWork W2110645972 @default.
- W4223492007 hasRelatedWork W2134332343 @default.
- W4223492007 hasRelatedWork W2302909420 @default.
- W4223492007 hasRelatedWork W37817669 @default.
- W4223492007 hasRelatedWork W4212949978 @default.
- W4223492007 hasRelatedWork W4294916325 @default.
- W4223492007 hasRelatedWork W4378952245 @default.
- W4223492007 hasVolume "22" @default.
- W4223492007 isParatext "false" @default.
- W4223492007 isRetracted "false" @default.
- W4223492007 workType "article" @default.